🚀 VC round data is live in beta, check it out!
Great Tree Pharmacy Valuation Multiples
Discover revenue and EBITDA valuation multiples for Great Tree Pharmacy and similar public comparables like DocMorris, Cawachi, JZJ Chain Drugstore, Dimed SA and more.
Great Tree Pharmacy Overview
About Great Tree Pharmacy
Great Tree Pharmacy Co Ltd is engaged in the management and trade of various drugs, health products, goods for mothers and babies, and cosmetics products. The firm also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, the company is also an agency for domestic and foreign healthcare products sold in clinics, outpatient centers, and medical communities.
Founded
2001
HQ
Employees
2.3K
Website
Sectors
Financials (LTM)
EV
$531M
Great Tree Pharmacy Financials
Great Tree Pharmacy reported last 12-month revenue of $618M and EBITDA of $50M.
In the same LTM period, Great Tree Pharmacy generated $178M in gross profit, $50M in EBITDA, and $20M in net income.
Revenue (LTM)
Great Tree Pharmacy P&L
In the most recent fiscal year, Great Tree Pharmacy reported revenue of $605M and EBITDA of $54M.
Great Tree Pharmacy expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $618M | XXX | $605M | XXX | XXX | XXX |
| Gross Profit | $178M | XXX | $172M | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 28% | XXX | XXX | XXX |
| EBITDA | $50M | XXX | $54M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 9% | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $20M | XXX | $19M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $22M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Great Tree Pharmacy Stock Performance
Great Tree Pharmacy has current market cap of $387M, and enterprise value of $531M.
Market Cap Evolution
Great Tree Pharmacy's stock price is $2.59.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $531M | $387M | 0.5% | XXX | XXX | XXX | $0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGreat Tree Pharmacy Valuation Multiples
Great Tree Pharmacy trades at 0.9x EV/Revenue multiple, and 10.6x EV/EBITDA.
EV / Revenue (LTM)
Great Tree Pharmacy Financial Valuation Multiples
As of April 19, 2026, Great Tree Pharmacy has market cap of $387M and EV of $531M.
Equity research analysts estimate Great Tree Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Great Tree Pharmacy has a P/E ratio of 19.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $387M | XXX | $387M | XXX | XXX | XXX |
| EV (current) | $531M | XXX | $531M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 10.6x | XXX | 9.7x | XXX | XXX | XXX |
| EV/EBIT | 23.2x | XXX | 24.1x | XXX | XXX | XXX |
| EV/Gross Profit | 3.0x | XXX | 3.1x | XXX | XXX | XXX |
| P/E | 19.4x | XXX | 20.1x | XXX | XXX | XXX |
| EV/FCF | 23.5x | XXX | 21.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Great Tree Pharmacy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Great Tree Pharmacy Margins & Growth Rates
Great Tree Pharmacy's revenue in the last 12 month grew by 8%.
Great Tree Pharmacy's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Great Tree Pharmacy's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Great Tree Pharmacy's rule of X is 27% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Great Tree Pharmacy Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | (6%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 27% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 21% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Great Tree Pharmacy Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Great Tree Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| DocMorris | XXX | XXX | XXX | XXX | XXX | XXX |
| Cawachi | XXX | XXX | XXX | XXX | XXX | XXX |
| JZJ Chain Drugstore | XXX | XXX | XXX | XXX | XXX | XXX |
| Dimed SA | XXX | XXX | XXX | XXX | XXX | XXX |
| YSB | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Great Tree Pharmacy M&A Activity
Great Tree Pharmacy acquired XXX companies to date.
Last acquisition by Great Tree Pharmacy was on XXXXXXXX, XXXXX. Great Tree Pharmacy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Great Tree Pharmacy
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialGreat Tree Pharmacy Investment Activity
Great Tree Pharmacy invested in XXX companies to date.
Great Tree Pharmacy made its latest investment on XXXXXXXX, XXXXX. Great Tree Pharmacy invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Great Tree Pharmacy
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Great Tree Pharmacy
| When was Great Tree Pharmacy founded? | Great Tree Pharmacy was founded in 2001. |
| Where is Great Tree Pharmacy headquartered? | Great Tree Pharmacy is headquartered in Taiwan. |
| How many employees does Great Tree Pharmacy have? | As of today, Great Tree Pharmacy has over 2K employees. |
| Is Great Tree Pharmacy publicly listed? | Yes, Great Tree Pharmacy is a public company listed on Taipei Exchange. |
| What is the stock symbol of Great Tree Pharmacy? | Great Tree Pharmacy trades under 6469 ticker. |
| When did Great Tree Pharmacy go public? | Great Tree Pharmacy went public in 2014. |
| Who are competitors of Great Tree Pharmacy? | Great Tree Pharmacy main competitors are DocMorris, Cawachi, JZJ Chain Drugstore, Dimed SA. |
| What is the current market cap of Great Tree Pharmacy? | Great Tree Pharmacy's current market cap is $387M. |
| What is the current revenue of Great Tree Pharmacy? | Great Tree Pharmacy's last 12 months revenue is $618M. |
| What is the current revenue growth of Great Tree Pharmacy? | Great Tree Pharmacy revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Great Tree Pharmacy? | Current revenue multiple of Great Tree Pharmacy is 0.9x. |
| Is Great Tree Pharmacy profitable? | Yes, Great Tree Pharmacy is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Great Tree Pharmacy? | Great Tree Pharmacy's last 12 months EBITDA is $50M. |
| What is Great Tree Pharmacy's EBITDA margin? | Great Tree Pharmacy's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Great Tree Pharmacy? | Current EBITDA multiple of Great Tree Pharmacy is 10.6x. |
| What is the current FCF of Great Tree Pharmacy? | Great Tree Pharmacy's last 12 months FCF is $23M. |
| What is Great Tree Pharmacy's FCF margin? | Great Tree Pharmacy's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Great Tree Pharmacy? | Current FCF multiple of Great Tree Pharmacy is 23.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.